Heparin in patients with HIT II requiring complex cardiac procedures

Thoracic and Cardiovascular Surgeon

Volumn 50, Issue 2, 2002, Pages 122-

  Christiansen, S ^a   Jahn, U R ^a   Hammel, D ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DANAPAROID; ENOXAPARIN; HEPARIN; HIRUDIN; THROMBOCYTE FACTOR 4;

ANTICOAGULANT THERAPY; BLEEDING; CARDIOPULMONARY BYPASS; DRUG CONTRAINDICATION; EXTRACORPOREAL CIRCULATION; HEART ASSIST DEVICE; HEART SURGERY; HEART TRANSPLANTATION; HUMAN; LETTER; PRIORITY JOURNAL; THROMBOCYTOPENIA; THROMBOEMBOLISM;

ANTICOAGULANTS; CARDIAC SURGICAL PROCEDURES; EXTRACORPOREAL CIRCULATION; HEPARIN; HUMANS; THROMBOCYTOPENIA;

EID: 0036102232     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-26686     Document Type: Letter

References (5)

1. "Heparin-free" cardiopulmonary bypass. First reported use of heparinoid (Org 10172) to provide anticoagulation for cardiopulmonary bypass
2. Undergoing cardiopulmonary bypass using enoxaparin only during a cardiac transplantation procedure
3. Anticoagulative management of patients requiring left ventricular assist device implantation and suffering from heparin-induced thrombocytopenia type II
4. Heparin in patients with heparin-induced thrombocytopenia type II requiring LVAD implantation and cardiac transplantation
5. Use of heparin during cardio-pulmonary bypass in patients with a history of heparin-induced thrombocytopenia